What is the full Sequential Organ Failure Assessment (SOFA) score?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is the Sequential Organ Failure Assessment (SOFA) Score?

The Sequential Organ Failure Assessment (SOFA) score is a validated clinical tool that evaluates dysfunction across six organ systems—respiratory, cardiovascular, brain, liver, kidney, and hemostasis—with each system scored 0-4 points for a total possible score of 0-24, where higher scores indicate worse organ dysfunction and increased mortality risk. 1

Core Components of the SOFA Score

The SOFA score assesses six major organ systems using specific clinical and biochemical parameters 2:

1. Respiratory System

  • Evaluated via PaO2/FiO2 ratio, ranging from 0 (≥400 mmHg) to 4 (<100 mmHg with mechanical ventilation) 1
  • When arterial blood gas data are unavailable, SpO2/FiO2 ratio can be substituted as a validated alternative 3

2. Cardiovascular System

  • Assessed through mean arterial pressure (MAP) and vasopressor requirements 1
  • Scoring ranges from 0 (MAP ≥70 mmHg) to 4 (high-dose dopamine >15 μg/kg/min or high-dose epinephrine/norepinephrine) 2

3. Brain (Neurological)

  • Evaluated using hepatic encephalopathy grade in cirrhotic patients or Glasgow Coma Scale in general ICU populations 2
  • Ranges from 0 (no encephalopathy) to 4 (Grade IV encephalopathy) 2

4. Liver

  • Assessed via serum bilirubin levels 2
  • Scoring ranges from 0 (<1.2 mg/dL) to 4 (≥12.0 mg/dL) 2

5. Kidney (Renal)

  • Evaluated through serum creatinine levels 2
  • Ranges from 0 (<1.2 mg/dL) to 4 (≥5.0 mg/dL) 2

6. Hemostasis (Coagulation)

  • Measured primarily by platelet count and INR 2
  • Scoring ranges from 0 (INR <1.1) to 4 (INR ≥2.5 or platelets ≤20,000/mm³) 2

Clinical Significance and Interpretation

Score Ranges and Mortality Risk

  • SOFA score of 2: Indicates mild single-organ dysfunction with relatively low mortality risk in general ICU populations 1
  • SOFA score increase of ≥2 points from baseline: In the presence of documented or suspected infection, this defines sepsis according to Sepsis-3 criteria and triggers immediate broad-spectrum antibiotics within 1 hour, fluid resuscitation, and source control 1, 4
  • SOFA scores 7-10: Indicate significant multi-organ dysfunction with substantially increased mortality risk 1
  • SOFA score >10: Predicts mortality exceeding 80-90% 1
  • SOFA score >11: Associated with >90% mortality 1, 5

Sequential Assessment

  • Calculate SOFA score on ICU admission using the most abnormal values from the first 24 hours 1
  • Reassess SOFA scores every 48-72 hours throughout the ICU stay to track disease progression and treatment response 1, 4
  • The "delta SOFA" (total maximum SOFA score minus admission total SOFA) provides valuable prognostic information about disease trajectory 5

Special Applications

In Cirrhosis and Acute-on-Chronic Liver Failure (ACLF)

The SOFA score was adapted for cirrhotic patients as the CLIF-SOFA score, which forms the basis for diagnosing and grading ACLF 2:

  • ACLF Grade Ia: Single renal failure (creatinine ≥2 mg/dL) 2
  • ACLF Grade Ib: Single non-kidney organ failure with mild renal dysfunction (creatinine 1.5-1.9 mg/dL) and/or hepatic encephalopathy grade I-II 2
  • ACLF Grade II: Two organ failures with 28-day mortality of 32% 2
  • ACLF Grade III: Three or more organ failures with 28-day mortality of 78% 2

In Sepsis Management

  • A SOFA score increase of ≥2 points from baseline in patients with documented or suspected infection meets Sepsis-3 criteria 1, 4
  • This triggers immediate initiation of broad-spectrum antibiotics within 1 hour, aggressive fluid resuscitation, and source control 1
  • Screen all septic patients for coagulopathy using the Sepsis-Induced Coagulopathy (SIC) scoring system, which incorporates SOFA score ≥2 as one component 6

Critical Limitations and Pitfalls

What SOFA Does NOT Account For

  • Age and comorbidities: Unlike APACHE II scoring systems, SOFA does not consider patient age or pre-existing conditions 1, 4
  • Gastrointestinal and immune dysfunction: These organ systems could not be incorporated due to insufficient data and lack of content validity 7, 8

Inappropriate Uses

  • Do not use SOFA alone for triage decisions in non-pandemic settings, as it lacks validation for resource allocation at low scores 1
  • Do not assume sepsis based solely on SOFA score ≥2 without documented infection 6
  • SOFA is a tool to augment, not replace, clinical judgment 6

Recent Updates: SOFA-2

A revised version (SOFA-2) was developed in 2025 to reflect contemporary clinical practice 7, 8:

  • Retains the same six organ systems but updates variables and thresholds to better describe current organ support treatments 7, 8
  • Maintains predictive validity with AUROC of 0.79 (95% CI, 0.76-0.81) compared to original SOFA AUROC of 0.77 (95% CI, 0.74-0.81) 8
  • Incorporates modern vasopressor dosing, mechanical ventilation practices, and organ support devices 7, 8

Practical Application Algorithm

  1. On ICU admission: Calculate baseline SOFA score using worst values from first 24 hours 1
  2. Every 48-72 hours: Reassess SOFA score to monitor disease trajectory 1, 4
  3. If SOFA increases by ≥2 points with infection: Diagnose sepsis and initiate immediate sepsis bundle (antibiotics within 1 hour, fluids, source control) 1
  4. If SOFA >10-11: Discuss goals of care and appropriateness of invasive interventions versus palliative measures, as mortality exceeds 90% 6
  5. Monitor delta SOFA: Static or increasing scores signal treatment failure requiring escalation of care 6, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.